Intensity Therapeutics所有資訊

Intensity Therapeutics | 4：持股變動聲明-高管 Talamo Joseph

10/23 16:27 (美東)

Intensity Therapeutics | 4：持股變動聲明-高管 Wesolowski John M

10/23 16:27 (美東)

Intensity Therapeutics | SC 13G：超過5%持股股東披露文件-LFP Management, LLC(5.4%)

06/07 17:32 (美東)

Intensity Therapeutics | 4：持股變動聲明-高管 Wesolowski John M

06/07 07:31 (美東)

Intensity Therapeutics | 4：持股變動聲明-董事 DUBIN THOMAS I H

05/15 22:24 (美東)

Intensity Therapeutics | 3：首次持股聲明-董事 DUBIN THOMAS I H

05/15 22:24 (美東)

Intensity Therapeutics | 4：持股變動聲明-高管 Wesolowski John M

03/07 18:11 (美東)

Intensity Therapeutics | 4：持股變動聲明-董事 Leahy Emer

03/07 18:06 (美東)

Intensity Therapeutics | 4：持股變動聲明-董事 GOLDBERG MARK A

03/07 18:06 (美東)

Intensity Therapeutics | 4：持股變動聲明-董事 Donovan Daniel

03/07 18:06 (美東)

Intensity Therapeutics | 4：持股變動聲明-高管 BENDER LEWIS H

03/07 18:06 (美東)

Intensity Therapeutics | SC 13G：超過5%持股股東披露文件-Lewis H. Bender(16.1%)

02/13 22:25 (美東)

Intensity Therapeutics | 4：持股變動聲明-首席財務官 Talamo Joseph

2023/12/12 08:17 (美東)

Intensity Therapeutics | 3：首次持股聲明-首席財務官 Talamo Joseph

2023/12/12 08:15 (美東)

Intensity Therapeutics | 4：持股變動聲明-高管 Wesolowski John M

2023/07/21 16:11 (美東)

Intensity Therapeutics | 3：首次持股聲明-高管 Wesolowski John M

2023/06/29 19:57 (美東)

Intensity Therapeutics | 3：首次持股聲明-高管 BENDER LEWIS H

2023/06/29 19:56 (美東)

Intensity Therapeutics | 3：首次持股聲明-董事 GOLDBERG MARK A

2023/06/29 19:56 (美東)

Intensity Therapeutics | 3：首次持股聲明-董事 Leahy Emer

2023/06/29 19:56 (美東)

Intensity Therapeutics | 3：首次持股聲明-董事 Donovan Daniel

2023/06/29 19:55 (美東)